A life science-focused investor is setting the stage for its anticipated Bay Area growth spurt with a $64.4 million acquisition in one of the biggest biotechnology regions of the United States.
A life science-focused investor is setting the stage for its anticipated Bay Area growth spurt with a $64.4 million acquisition in one of the biggest biotechnology regions of the United States.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
1720 El Camino Real, Burlingame, CA
Real Estate